HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF

This article was originally published in The Rose Sheet

Executive Summary

Bush Boake Allen acquisition leads to 14.4% sales increase in fourth quarter and 1.4% sales growth for year, International Flavors & Fragrances says. Consolidated Q4 sales totaled $384.5 mil. and annual sales were $1.46 bil., while sales excluding the BBA acquisition were $318.6 mil. for the quarter, a decline of 5%, and $1.4 bil. for the year, a loss of 3%. IFF announced it would acquire BBA in September (1"The Rose Sheet" Oct. 2, 2000, p. 11). Fragrance sales were led by Europe, Africa and the Middle East and North America with 15% and 7% gains, respectively. In the fourth quarter, the company recorded a $24.2 mil. charge related to integration of BBA and a restructuring initiative separating the flavors and fragrances businesses (2"The Rose Sheet" Oct. 9, 2000, p. 5). Total restructuring cost will be $90 mil.-$100 mil. through mid-2002, company says

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel